A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes (Q42607495)
Jump to navigation
Jump to search
scientific article published on November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes |
scientific article published on November 2008 |
Statements
1 reference
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes (English)
1 reference
Priscilla Hollander
1 reference
John Cooper
1 reference
Jesper Bregnhøj
1 reference
Claus Bang Pedersen
1 reference
1 November 2008
1 reference
1 reference
Identifiers
1 reference